Recursion Pharmaceuticals, Inc.

RXRXNASDAQ Global Select·USD·Closed

RXRXNASDAQ·USD·Closed

$3.00

−1.32%

$3.00

−$0.04 (1.32%)

52W Range

5thpctl

Volume

0.74×avg

Mkt Cap

1.57BUSD

P/E

-2.5TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

5thpctl

Volume

0.74×avg

Market Cap

1.57BUSD

P/E Ratio

-2.5TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+26.9% / yr

Operating margin-882.9%

ROIC-47.1%

Financially safe

Stretched

Debt / equity0.07×

Interest coverage-351.9×

Current ratio5.47×